이상반응 보고
| VAERS ID | 1576384 |
|---|---|
| 성별 | 여성 |
| 나이 | 30세 |
| 주 코드 | FR |
| 제약회사 | MODERNA |
| 로트 번호 | 3003608 |
| 예방접종 횟수 | 1 |
| 접종일 | 2021-07-29 |
| 발병일 | 2021-07-29 |
| 상태 | 회복 |
증상
- 발열(Pyrexia)
- 인플루엔자와 같은 질병(Influenza like illness)
- SARS-CoV-2 테스트(SARS-CoV-2 test)
- 임신 중 모성 노출(Maternal exposure during pregnancy)
이환 중 질병
Pregnancy
지병
Medical History/Concurrent Conditions: Lactation decreased
기타 의료
FOLIC ACID
이전 예방접종
알레르기
임상 검사
Test Date: 20210802; Test Name: COVID-19 virus test; Test Result: Negative ; Result Unstructured Data: Negative
증상 상세
Maternal exposure during pregnancy; Flu-like aching; High temperature; This regulatory authority prospective pregnancy case was reported by a consumer and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (Maternal exposure during pregnancy), INFLUENZA LIKE ILLNESS (Flu-like aching) and PYREXIA (High temperature) in a 30-year-old female patient (gravida 1) who received mRNA-1273 (Moderna CoviD-19 Vaccine) (batch no.
3003608) for COVID-19 vaccination.
The patient's past medical history included Lactation decreased.
Concurrent medical conditions included Pregnancy.
Concomitant products included FOLIC ACID for Folic acid supplementation.
On 29-Jul-2021, the patient received second dose of mRNA-1273 (Moderna CoviD-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form.
On an unknown date, the patient received first dose of mRNA-1273 (Moderna CoviD-19 Vaccine) (unknown route) 1 dosage form.
Last menstrual period and estimated date of delivery were not provided.
On 29-Jul-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Maternal exposure during pregnancy) (seriousness criterion medically significant), INFLUENZA LIKE ILLNESS (Flu-like aching) (seriousness criterion medically significant) and PYREXIA (High temperature) (seriousness criterion medically significant).
The patient was treated with PARACETAMOL for Adverse event, at an unspecified dose and frequency.
On 30-Jul-2021, INFLUENZA LIKE ILLNESS (Flu-like aching) and PYREXIA (High temperature) had resolved.
At the time of the report, MATERNAL EXPOSURE DURING PREGNANCY (Maternal exposure during pregnancy) outcome was unknown.
Not Provided DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 02-Aug-2021, SARS-CoV-2 test: negative (Negative) Negative.
The action taken with mRNA-1273 (Moderna CoviD-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna CoviD-19 Vaccine) (Unknown) was unknown.
Patient reported she experienced feeling poorly, body started aching after 8 hours of received vaccine.
after 14 hours she had high temperature.
Company Comment: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
This is a case of product exposure during pregnancy with associated AE for this 30-year-old female.
This case was linked to MOD-2021-280397 (Parent-Child Link).
See case MOD-2021-280397 for details regarding the child case.
; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
This is a case of product exposure during pregnancy with associated AE for this 30-year-old female.